Join Oxford Global at the 4th Annual NGS & Clinical Diagnostics USA Congress 2018 to discuss the future of sequencing with key innovators from Pharma, Healthcare and Academia! Featuring over 50 presentations and case studies looking at emerging trends in NGS data analysis, clinical diagnostics and biomarker development as well as novel therapeutic applications, this congress will bring together over 200 senior level attendees.

Pharma – Learn more about NGS in pharmaceutical research and development! Critical case studies and presentations on: whole genome se quencing applications; NGS in clinical trials and NGS in biomarker development.

Healthcare – NGS is revolutionising healthcare, allowing clinicians to take a more personalised approach to care. New for 2018 the congress will be looking at NGS and metagenomics, improved next generation sequencing techniques in liquid biopsy as well NGS in precision medicine.

Academic – Hear about the latest research in the field looking at new technologies and techniques. Critical areas include advances in NGS data analysis, long read vs. short read sequencing and novel therapeutic applications.